Method for treatment of cancers and antineoplastic pharmaceutical formulations
AssigneeCanada Inc.
InventorsAdrian Mihail, Nicolae Mihail
Life of this patent
Estimating the term…
Abstract
A method of therapy based on a pharmaceutical composition that has an irreversible effect of inhibiting the malignancy of tumors and cancers that comprises an effective ingredient is disclosed. The effective ingredient can be used in combination with a vector and/or metabolite that is specific to the malignant cells. This effect of blocking the malignancy without killing the cells is new, specific, and has been called malignodepriving inactivation.
Claims13
A method of treating cancer by administering a therapeutic composition that inhibits the malignancy of cells.
A therapeutic anticancer composition, which comprises a therapeutically effective amount of an anticancer agent, wherein the anticancer agent is a triphenylmethane dye, or pharmaceutically acceptable salts of it.
A therapeutic anticancer composition, which comprises a therapeutically effective amount of an anticancer agent, wherein the anticancer agent is isometamidium chloride C28H26C1N7 or 3-amino-8-[3-[3-(aminoiminomethyl)phenyl]-1-triazenyl]-5-ethyl-6-phenyl-,chloride.
Dependencies are inferred from the claim text.